Oxford Cancer Analytics

OXCan

This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.

Mercy BioAnalytics

This company develops blood-based liquid biopsy tests for early cancer detection, serving healthcare providers, pharmaceutical companies and clinical trial organisers.

Aerion Bioscience

This company develops a blood test using a six-protein panel and algorithm to detect lung cancer in high-risk individuals.

Delfi Diagnostics

This company develops blood-based liquid biopsy tests for early cancer detection and treatment monitoring for healthcare providers, health systems, and biopharmaceutical partners.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.

Amadix

This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.

Infiniplex

This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.

Voc Diagnostics

This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.